Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis

Pulm Pharmacol Ther. 2015 Jun:32:1-6. doi: 10.1016/j.pupt.2015.03.005. Epub 2015 Apr 9.

Abstract

Background: Increased oxidative stress is supposed to be involved in the etiology of idiopathic pulmonary fibrosis (IPF). It was reported that oxidative stress values measured by a spectrophotometric technique (d-ROMs test) were significantly higher in IPF patients than in controls, and were negatively correlated with Forced Vital Capacity (FVC) and Carbon Monoxide Diffusing Capacity (DLCO). However, the relationship between progression of IPF over time and change in serum oxidative stress marker remains unclarified.

Aims: This study aimed to investigate the change in serum oxidative stress marker during progression of IPF.

Subjects and methods: The levels of oxidative stress in blood samples of 43 treatment-naïve IPF patients were measured by the d-ROMs test. FVC and DLCO were measured concurrently. The changes in oxidative stress and pulmonary function were evaluated in 27 untreated patients 6 months later. Oxidative stress levels of 13 patients with acute exacerbation of IPF (AE-IPF) and 30 healthy controls were also evaluated.

Results: Oxidative stress values [median, interquartile range (IQR); Carratelli units (U.CARR)] were significantly higher in 43 IPF patients than in controls (366, 339-443 vs. 289, 257-329, p < 0.01) and were significantly increased 6 months later in 27 untreated patients (353, 311-398 at baseline to 385, 345-417 at follow-up, p < 0.01). The increase in oxidative stress values (24.0, 6.0-49.0 U.CARR/6 months) was negatively correlated with baseline DLCO (rs = -0.44, p < 0.05) and FVC changes after 6 months (rs = -0.54, p < 0.01). Oxidative stress values were significantly higher in IPF patients with acute exacerbation than in those with stable disease (587, 523-667 vs. 366, 339-443 U.CARR, respectively; p < 0.01).

Conclusions: Serum oxidative stress values increased with disease progression in IPF patients.

Keywords: Acute exacerbation; Lung function; Serum biomarker; d-ROMs test.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Carbon Monoxide / metabolism*
  • Case-Control Studies
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Idiopathic Pulmonary Fibrosis / physiopathology*
  • Male
  • Middle Aged
  • Oxidative Stress*
  • Vital Capacity

Substances

  • Biomarkers
  • Carbon Monoxide